GSK-J4 (hydrochloride) |
An ethyl ester prodrug of the JMJD3 selective histone demethylase inhibito… |
50 mg |
12073-50 |
More Info
|
GSK-J5 (hydrochloride) |
A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… |
1 mg |
12074-1 |
More Info
|
GSK-J5 (hydrochloride) |
A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… |
10 mg |
12074-10 |
More Info
|
GSK-J5 (hydrochloride) |
A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… |
5 mg |
12074-5 |
More Info
|
GSK-J5 (hydrochloride) |
A pyridine regio-isomer of the JMJD3 inhibitor GSK-J4; cell-permeable and… |
50 mg |
12074-50 |
More Info
|
GSK-J1 (sodium salt) |
A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… |
1 mg |
12054-1 |
More Info
|
GSK-J1 (sodium salt) |
A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… |
10 mg |
12054-10 |
More Info
|
GSK-J1 (sodium salt) |
A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… |
5 mg |
12054-5 |
More Info
|
GSK-J1 (sodium salt) |
A potent, cell impermeable inhibitor of the H3K27 histone demethylases JMJ… |
50 mg |
12054-50 |
More Info
|
GSK-J2 (sodium salt) |
A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) |
1 mg |
12056-1 |
More Info
|
GSK-J2 (sodium salt) |
A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) |
10 mg |
12056-10 |
More Info
|
GSK-J2 (sodium salt) |
A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) |
5 mg |
12056-5 |
More Info
|
GSK-J2 (sodium salt) |
A negative control compound for GSK-J1 (IC50 = >100 µM for JMJD3) |
50 mg |
12056-50 |
More Info
|
GSK-LSD1 (hydrochloride) |
An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… |
1 mg |
16439-1 |
More Info
|
GSK-LSD1 (hydrochloride) |
An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… |
10 mg |
16439-10 |
More Info
|
GSK-LSD1 (hydrochloride) |
An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… |
25 mg |
16439-25 |
More Info
|
GSK-LSD1 (hydrochloride) |
An irreversible, mechanism-based inhibitor of LSD1 (IC50 = 16 nM); induces… |
5 mg |
16439-5 |
More Info
|
GSK121 (trifluoroacetate salt) |
The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… |
1 mg |
17491-1 |
More Info
|
GSK121 (trifluoroacetate salt) |
The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… |
10 mg |
17491-10 |
More Info
|
GSK121 (trifluoroacetate salt) |
The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… |
5 mg |
17491-5 |
More Info
|
GSK121 (trifluoroacetate salt) |
The initial compound identified in a screen for PAD4 inhibitors (IC50 = 3.… |
500 µg |
17491-500 |
More Info
|
G-418 (sulfate) |
An aminoglycoside antibiotic; active against T. thermophila (IC50 = 10 &mi… |
1 g |
13200-1 |
More Info
|
G-418 (sulfate) |
An aminoglycoside antibiotic; active against T. thermophila (IC50 = 10 &mi… |
5 g |
13200-5 |
More Info
|
GT 2016 |
An antagonist of histamine H3 receptors (Ki = 43.8 nM); selective for H3 o… |
1 mg |
11996-1 |
More Info
|
GT 2016 |
An antagonist of histamine H3 receptors (Ki = 43.8 nM); selective for H3 o… |
10 mg |
11996-10 |
More Info
|